Mainz Biomed B.V. EBITDA for the year ending December 31, 2024: USD -19.56 M

Mainz Biomed B.V. EBITDA is USD -19.56 M for the year ending December 31, 2024, a -21.80% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Mainz Biomed B.V. EBITDA for the year ending December 31, 2023 was USD -25.01 M, a -2.75% change year over year.
  • Mainz Biomed B.V. EBITDA for the year ending December 31, 2022 was USD -25.72 M.
  • Mainz Biomed B.V. EBITDA for the year ending December 31, 2020 was USD -257.64 K, a -63.30% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)